HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keon Hee Yoo Selected Research

Alanine (L-Alanine)

1/2021A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keon Hee Yoo Research Topics

Disease

42Neoplasms (Cancer)
11/2023 - 01/2007
23Neuroblastoma
11/2022 - 08/2002
11Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2021 - 01/2007
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 09/2007
8Graft vs Host Disease (Graft-Versus-Host Disease)
01/2023 - 11/2010
7Infections
02/2022 - 09/2010
6Leukemia
05/2021 - 03/2012
5Medulloblastoma
01/2020 - 04/2007
5Hematologic Neoplasms (Hematological Malignancy)
06/2018 - 04/2006
4Residual Neoplasm
11/2022 - 03/2013
4Neoplasm Metastasis (Metastasis)
04/2021 - 03/2013
4Inflammation (Inflammations)
12/2020 - 11/2011
4Germinoma
11/2020 - 03/2010
3Philadelphia Chromosome
12/2023 - 12/2019
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2023 - 12/2019
3Neutropenia
01/2022 - 01/2020
3Fever (Fevers)
01/2021 - 03/2011
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2016 - 03/2013
3Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2015 - 03/2010
2Osteosarcoma (Osteogenic Sarcoma)
01/2023 - 01/2016
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2023 - 01/2020
2Juvenile Myelomonocytic Leukemia
01/2023 - 01/2023
2Brain Neoplasms (Brain Tumor)
12/2020 - 12/2014
2Osteoarthritis
12/2020 - 05/2020
2Lymphoma (Lymphomas)
11/2020 - 11/2013
2Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2020 - 09/2010
2Chronic Granulomatous Disease
01/2020 - 07/2013
2Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2019 - 03/2012
2Ependymoma
01/2018 - 04/2012
2Glioma (Gliomas)
02/2017 - 01/2012
2Hypoxia (Hypoxemia)
11/2016 - 01/2016
2Sarcoma (Soft Tissue Sarcoma)
07/2016 - 06/2010
2Aplastic Anemia (Anemia, Hypoplastic)
01/2016 - 11/2010
2Aspergillosis
02/2013 - 01/2013
2Primitive Neuroectodermal Tumors (PNET)
06/2010 - 04/2007
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2023
1Bronchiolitis Obliterans Syndrome
11/2022
1Cytomegalovirus Infections (Inclusion Disease)
02/2022
1Headache (Headaches)
01/2021
1Septic Shock (Toxic Shock Syndrome)
10/2020
1Bacteremia
10/2020

Drug/Important Bio-Agent (IBA)

5LigandsIBA
01/2022 - 06/2012
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2021 - 11/2010
4Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2007
3Imatinib Mesylate (Gleevec)FDA Link
12/2023 - 12/2019
3nilotinibFDA Link
12/2023 - 12/2019
33-Iodobenzylguanidine (Iobenguane)IBA
01/2022 - 01/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2011
3Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2017
3fludarabineIBA
05/2021 - 11/2010
32-mercaptopurineIBA
01/2021 - 07/2018
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
12/2020 - 01/2012
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2020 - 06/2009
3Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
11/2020 - 03/2010
3Phosphopyruvate Hydratase (Enolase)IBA
04/2020 - 06/2009
3Cisplatin (Platino)FDA LinkGeneric
05/2019 - 03/2011
3Carboplatin (JM8)FDA LinkGeneric
01/2017 - 03/2011
3Etoposide (VP 16)FDA LinkGeneric
01/2017 - 06/2012
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
10/2016 - 08/2010
3Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2016 - 11/2010
2Dasatinib (BMS 354825)FDA Link
12/2023 - 01/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 08/2015
2Thioguanine (Tioguanine)FDA Link
01/2021 - 01/2010
2Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 03/2011
2Antiviral Agents (Antivirals)IBA
01/2020 - 10/2012
2Caspase 8 (Caspase-8)IBA
05/2019 - 06/2012
2Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
04/2017 - 01/2010
2Melphalan (Alkeran)FDA LinkGeneric
01/2017 - 12/2014
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2017 - 12/2014
2EverolimusFDA Link
11/2016 - 08/2015
2ChemokinesIBA
11/2016 - 01/2016
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2015 - 03/2010
2AntigensIBA
02/2013 - 03/2011
2Ferritins (Ferritin)IBA
04/2012 - 06/2009
2Inhibitor of Apoptosis ProteinsIBA
09/2007 - 01/2007
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2007 - 01/2007
1ibrutinibIBA
11/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
02/2022
1Iodine-123IBA
01/2022
1Clofarabine (Clolar)FDA Link
10/2021
1NucleotidesIBA
01/2021
1TransferasesIBA
01/2021
1BilirubinIBA
01/2021
1Alanine (L-Alanine)FDA Link
01/2021
1Rosiglitazone (Avandia)FDA Link
12/2020
1CollagenIBA
12/2020
1(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
12/2020
1Amikacin (A.M.K)FDA LinkGeneric
10/2020

Therapy/Procedure

45Drug Therapy (Chemotherapy)
11/2023 - 08/2002
26Stem Cell Transplantation
01/2023 - 08/2002
18Therapeutics
11/2022 - 12/2002
13Transplantation
01/2023 - 09/2010
10Hematopoietic Stem Cell Transplantation
01/2023 - 09/2010
10Radiotherapy
12/2020 - 12/2002
7Cell Transplantation
01/2023 - 11/2010
7Induction Chemotherapy
11/2020 - 03/2012
2Combined Modality Therapy
12/2020 - 01/2018
2Craniospinal Irradiation
12/2020 - 01/2019
2Cell- and Tissue-Based Therapy (Cell Therapy)
06/2018 - 01/2016
1Adjuvant Radiotherapy
04/2021